These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 22487082)

  • 21. A chemical proteomics approach for the search of pharmacological targets of the antimalarial clinical candidate albitiazolium in Plasmodium falciparum using photocrosslinking and click chemistry.
    Penarete-Vargas DM; Boisson A; Urbach S; Chantelauze H; Peyrottes S; Fraisse L; Vial HJ
    PLoS One; 2014; 9(12):e113918. PubMed ID: 25470252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective inhibition of an apicoplastic aminoacyl-tRNA synthetase from Plasmodium falciparum.
    Hoen R; Novoa EM; López A; Camacho N; Cubells L; Vieira P; Santos M; Marin-Garcia P; Bautista JM; Cortés A; Ribas de Pouplana L; Royo M
    Chembiochem; 2013 Mar; 14(4):499-509. PubMed ID: 23444099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paradigm shifts in malaria parasite biochemistry and anti-malarial chemotherapy.
    Surolia N; RamachandraRao SP; Surolia A
    Bioessays; 2002 Feb; 24(2):192-6. PubMed ID: 11835284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemoglobin Degrading Proteases of Plasmodium falciparum as Antimalarial Drug Targets.
    Qidwai T
    Curr Drug Targets; 2015; 16(10):1133-41. PubMed ID: 25738296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of Putative Apicoplast-Targeting Drugs Using a Chemical Supplementation Assay in Cultured Human Malaria Parasites.
    Uddin T; McFadden GI; Goodman CD
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29109165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. That was then but this is now: malaria research in the time of an eradication agenda.
    Kappe SH; Vaughan AM; Boddey JA; Cowman AF
    Science; 2010 May; 328(5980):862-6. PubMed ID: 20466924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitamin B metabolism in Plasmodium falciparum as a source of drug targets.
    Müller IB; Hyde JE; Wrenger C
    Trends Parasitol; 2010 Jan; 26(1):35-43. PubMed ID: 19939733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasmodium falciparum Resistance to a Lead Benzoxaborole Due to Blocked Compound Activation and Altered Ubiquitination or Sumoylation.
    Sindhe KMV; Wu W; Legac J; Zhang YK; Easom EE; Cooper RA; Plattner JJ; Freund YR; DeRisi JL; Rosenthal PJ
    mBio; 2020 Jan; 11(1):. PubMed ID: 31992618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Understanding the biology of the Plasmodium falciparum apicoplast; an excellent target for antimalarial drug development.
    Chakraborty A
    Life Sci; 2016 Aug; 158():104-10. PubMed ID: 27381078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apicoplast translation, transcription and genome replication: targets for antimalarial antibiotics.
    Dahl EL; Rosenthal PJ
    Trends Parasitol; 2008 Jun; 24(6):279-84. PubMed ID: 18450512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quinoline-resistance reversing agents for the malaria parasite Plasmodium falciparum.
    van Schalkwyk DA; Egan TJ
    Drug Resist Updat; 2006; 9(4-5):211-26. PubMed ID: 17064951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequence polymorphisms in pfcrt are strongly associated with chloroquine resistance in Plasmodium falciparum.
    Chen N; Russell B; Staley J; Kotecka B; Nasveld P; Cheng Q
    J Infect Dis; 2001 May; 183(10):1543-5. PubMed ID: 11319698
    [No Abstract]   [Full Text] [Related]  

  • 33. Strategies to reverse drug resistance in malaria.
    Egan TJ; Kaschula CH
    Curr Opin Infect Dis; 2007 Dec; 20(6):598-604. PubMed ID: 17975410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional consequences of perturbing polyamine metabolism in the malaria parasite, Plasmodium falciparum.
    Clark K; Niemand J; Reeksting S; Smit S; van Brummelen AC; Williams M; Louw AI; Birkholtz L
    Amino Acids; 2010 Feb; 38(2):633-44. PubMed ID: 19997948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.
    Lekana-Douki JB; Dinzouna Boutamba SD; Zatra R; Zang Edou SE; Ekomy H; Bisvigou U; Toure-Ndouo FS
    Infect Genet Evol; 2011 Mar; 11(2):512-7. PubMed ID: 21251998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mapping of a Plasmodium falciparum pfcrt K76T mutation: a useful strategy for controlling chloroquine resistance in Madagascar.
    Ariey F; Randrianarivelojosia M; Duchemin JB; Rakotondramarina D; Ouledi A; Robert V; Jambou R; Jahevitra M; Andrianantenaina H; Raharimalala L; Mauclère P
    J Infect Dis; 2002 Mar; 185(5):710-2. PubMed ID: 11865433
    [No Abstract]   [Full Text] [Related]  

  • 37. Enzymes of pyrimidine salvage pathways in intraerythrocytic Plasmodium falciparum.
    Naguib FNM; Wilson CM; El Kouni MH
    Int J Biochem Cell Biol; 2018 Dec; 105():115-122. PubMed ID: 30381242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apicoplast Metabolism: Parasite's Achilles' Heel.
    Kadian K; Gupta Y; Singh HV; Kempaiah P; Rawat M
    Curr Top Med Chem; 2018; 18(22):1987-1997. PubMed ID: 30499407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitors of Plasmodium falciparum methionine aminopeptidase 1b possess antimalarial activity.
    Chen X; Chong CR; Shi L; Yoshimoto T; Sullivan DJ; Liu JO
    Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14548-53. PubMed ID: 16983082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. cAMP-dependent protein kinase from Plasmodium falciparum: an update.
    Wurtz N; Chapus C; Desplans J; Parzy D
    Parasitology; 2011 Jan; 138(1):1-25. PubMed ID: 20663247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.